Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 317 of 6351
-
New biologic MK-1045 targets Hard-to-Treat blood cancers
Disease control Not yet recruitingResearchers are looking for new ways to treat people with B-cell cancers. In this trial, researchers will look at chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). These are blood cancers that affect B-cells in the blood, bone marrow, or lymph nodes. The g…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Hope for families: new drug trial targets autism irritability in kids
Symptom relief Not yet recruitingThe purpose of this study is to assess KarXT + KarX-EC for the treatment of irritability associated with autism in children and adolescents.
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
New hope for cancer survivors: drug aims to shield against Life-Threatening infections
Disease control Recruiting nowThis is a prospective, multicenter, open-label, single-arm study to assess the efficacy, safety, and pharmacokinetics (PK) of IgPro20 in adults with hematologic malignancies treated with B-cell targeting Chimeric antigen receptor T-cell (CAR T-cell) and T-cell redirecting therapi…
Phase 3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
Could a new pill tame Autism-Related irritability in kids?
Symptom relief Not yet recruitingThe purpose of this study is to assess KarXT + KarX-EC for the treatment of irritability associated with autism in children and adolescents.
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Can a patch of your own retina restore clearer vision?
Disease control Not yet recruitingIdiopathic epiretinal membrane is a condition in which abnormal tissue grows on the surface of the retina and can cause blurred vision and distortion. The standard surgical treatment is removal of this membrane, but some patients may not achieve complete visual recovery because t…
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can tiny ear seeds replace opioids for back pain?
Symptom relief Not yet recruitingPatients frequently present to the emergency department for treatment of acute pain. In the emergency department, analgesic medications, particularly opiates, are most often the primary and only means of treatment. Alternative therapies such as traditional acupuncture have been s…
Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Can a new drug clear the skin in lichen planus?
Disease control Recruiting nowThis study will evaluate the safety and efficacy of GIA632 in participants with moderate to severe cutaneous lichen planus (cLP).
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a purple berry calm kidney disease inflammation?
Disease control Not yet recruitingChronic kidney disease (CKD) is a highly prevalent condition in Chile and worldwide and is associated with a substantial burden of morbidity, particularly cardiovascular morbidity. In the early stages of CKD, treatment aims to preserve kidney function and slow the progression of …
Sponsor: Universidad Mayor • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a new nerve block match the gold standard for Post-Surgery pain?
Symptom relief Not yet recruitingThis multicentre, randomized, assessor-blinded, non-inferiority trial will compare the analgesic efficacy of bilateral superficial parasternal intercostal plane (SPIP) block with bilateral erector spinae plane (ESP) block in adults undergoing first-time on-pump cardiac surgery th…
Sponsor: Ondokuz Mayıs University • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Can a single drug tame multiple autoimmune diseases?
Disease control Not yet recruitingThe purpose of this study is to learn about the safety and effects of the study medication called PF-08154225 for the potential treatment of autoimmune diseases. An autoimmune disease is a condition that makes a person's immune system attack its healthy cells by mistake. This stu…
Phase 1/2 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a cocktail of nerve blocks replace opioids after heart bypass?
Symptom relief Recruiting nowIn cardiac surgery patients , effective pain control is crucial to support early extubation, mobilization, and cognitive recovery, yet systemic opioids carry substantial risks such as respiratory depression, delirium, and delayed rehabilitation. While regional fascial plane block…
Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Can a smarter pacemaker lead placement spare the heart after surgery?
Disease control Not yet recruitingConventional right ventricular pacing has been associated with ventricular dyssynchrony and an increased risk of pacing-induced cardiomyopathy, which may lead to worse clinical outcomes. To lessen the burden of pacing-induced cardiomyopathy, the adoption of conduction system paci…
Sponsor: Sahlgrenska University Hospital • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a Pharmacist's advice boost anemia treatment in pregnancy?
Disease control Not yet recruitingAnemia is a major public health problem among pregnant women, particularly in low- and middle-income countries. It is characterized by a reduction in hemoglobin concentration or the oxygen-carrying capacity of the blood, which may be insufficient to meet the physiological needs o…
Sponsor: Hamdard University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a special diet before heart surgery cut the need for blood transfusions?
Disease control Not yet recruiting1. To test the effect and feasibility of culturally relevant SNP program in Anaemic patients scheduled for elective open-heart surgery versus those getting usual preoperative care in a public sector hospital. 2. To evaluate the incidence of transfusion during intra-operative and …
Phase 3 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a pacemaker slip in through the neck vein?
Disease control Not yet recruitingThis study is a prospective, single-arm, single-center feasibility study evaluating the safety and feasibility of transjugular (internal jugular vein) implantation of the Aveir VR leadless ventricular pacemaker in patients requiring ventricular pacing. A total of 15 patients will…
Sponsor: Min Shen • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can an antioxidant boost the Body's fight against a deadly infection in cirrhosis?
Disease control Not yet recruitingSpontaneous bacterial peritonitis (SBP) is one of the most serious infectious complications of liver cirrhosis and ascites. It affects approximately 10-30% of hospitalized patients with decompensated cirrhosis and carries an in-hospital mortality of 20-40% despite appropriate ant…
Phase 1/2 • Sponsor: Tanta University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a dash of spice and protein shield muscle during Weight-Loss shots?
Disease control Recruiting nowThis pilot study will examine whether daily protein supplementation with or without a mixture of culinary spices can help preserve muscle mass and function in adults who are using GLP-1 medications for weight management. The study will include 75 adults who recently started a GL…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for ovarian cancer: targeted drug combo takes on resistant tumors
Disease control Not yet recruitingThis phase II trial compares the effect of sacituzumab govitecan and bevacizumab to standard care (carboplatin, pegylated liposomal doxorubicin, and bevacizumab) in patients with ovarian cancer that has come back after an initial response to platinum therapy (platinum-sensitive),…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a custom mRNA vaccine keep ovarian cancer from coming back?
Disease control Recruiting nowThis is a Phase I, single-arm, open-label, prospective, non-randomized, single-center dose-escalation study. The study will evaluate the safety, tolerability, and preliminary activity of the NeoOVSV mRNA-lipid nanoparticle vaccine in patients with stage II/III ovarian cancer afte…
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
Can a new pill quiet stubborn chronic hives?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if different doses of TLL-018 works to treat in moderate-to-severe chronic spontaneous urticaria (CSU) participants . It will also learn about the safety of TLL-018. The main questions it aims to answer are: Which is the best regimen o…
Phase 2 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC